0001667699-22-000001.txt : 20220218
0001667699-22-000001.hdr.sgml : 20220218
20220217202945
ACCESSION NUMBER: 0001667699-22-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220218
DATE AS OF CHANGE: 20220217
EFFECTIVENESS DATE: 20220218
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Renibus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001667699
IRS NUMBER: 810872431
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-349442
FILM NUMBER: 22650485
BUSINESS ADDRESS:
STREET 1: 950 E. STATE HIGHWAY 114
STREET 2: STE-160
CITY: SOUTHLAKE
STATE: TX
ZIP: 76092
BUSINESS PHONE: 386-527-1071
MAIL ADDRESS:
STREET 1: 950 E. STATE HIGHWAY 114
STREET 2: STE-160
CITY: SOUTHLAKE
STATE: TX
ZIP: 76092
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001667699
Renibus Therapeutics, Inc.
181 Grand Avenue
Suite 225
Southlake
TX
TEXAS
76092
817.722.5768
DELAWARE
None
None
Corporation
true
Alvaro
Guillem
181 Grand Avenue
Suite 225
Southlake
TX
TEXAS
76092
Director
Chairman of the Board
D.
Jeffrey
Keyser
181 Grand Avenue
Suite 225
Southlake
TX
TEXAS
76092
Executive Officer
Director
President, Secretary and Chief Operating Officer
Henrik
Rasmussen
181 Grand Avenue
Suite 225
Southlake
TX
TEXAS
76092
Director
Bhupinder
Singh
181 Grand Avenue
Suite 225
Southlake
TX
TEXAS
76092
Director
Frank
Stonebanks
181 Grand Avenue
Suite 225
Southlake
TX
TEXAS
76092
Executive Officer
Director
Chief Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
true
0001667699-19-000003
2019-09-12
false
true
true
false
0
Melior Capital Management GMBH
None
None
None
Baarerstrasse 12
Zug
V8
SWITZERLAND
6300
MA
MASSACHUSETTS
true
34614335
34614335
0
false
30
116640
0
In addition, Recipient earned a warrant to purchase equity in the issuer with an initial value equal to 4.0% of the aggregate number of securities issued to investors introduced to issuer by Recipient
0
false
Renibus Therapeutics, Inc.
/s/ Frank Stonebanks
Frank Stonebanks
Chief Executive Officer
2022-02-17